Abstract
Background: In 2024, type 2 diabetes mellitus (T2DM) – a public health challenge – affected 589 million adults worldwide. In South Africa, the prevalence is estimated at 15%, contributing to approximately 3.4 million deaths. Achieving optimal glycaemic control in patients is challenging, resulting in preventable complications and deaths. Systemic reforms and targeted interventions are urgently required.
Aim: To identify barriers faced by healthcare professionals (HCPs) to effectively manage patients with T2DM.
Setting: A survey was conducted in the Tshwane Metropolitan Municipality, Gauteng province, South Africa.
Methods: The study involved 205 HCPs across 22 clinics and 6 community health centres from May 2022 to June 2022. Data were analysed descriptively. Categorical variables were compared using Fisher’s exact test and a p-value of < 0.05 was considered significant.
Results: Most participants were nurses (84%), < 50 years (65%), female (87%), black people (64.7%), and > 10 years experience (65%) and had academic and in-house training on T2DM (38.5%). Key barriers faced by HCPs in managing patients with T2DM included workload making it difficult monitor patients (53%) and screen for complications (57%), time pressures to deliver quality care (59%) and educate patients (69%), inadequate insulin initiation knowledge (68%) and lack of continuity of care (62%).
Conclusion: Excessive workloads, insufficient staffing, time pressures, insulin inertia, and knowledge gaps – impede the delivery of personalised care, patient education and monitoring.
Contribution: Addressing these challenges will require collaborative care models, workforce optimisation, targeted training, better resource allocation and health technology and can significantly improve patient outcomes and alleviate burden among HCPs.
Keywords: type 2 diabetes mellitus; primary healthcare; barriers; workload pressure; effective management.
Introduction
Globally, type 2 diabetes mellitus (T2DM) is a growing public health concern that has become increasingly prevalent in recent years. In 2024, it is estimated that 589 million adults aged between 20 and 79 years were living with diabetes, worldwide, and this number is projected to reach 853 million by 2050.1 In the African continent, the situation is particularly worrisome, with projections indicating a significant rise in the prevalence of T2DM from 3.2% to 3.7% by the year 2040.2 This troubling trend is also reflected in South Africa, where studies have reported a wide range of prevalence rates, from 7% to as high as 15% among the adult population.2,3,4,5,6 In another study, the pooled prevalence of T2DM in South Africa was estimated at 15.25%.7 In 2024, approximately 3.4 million adults aged 20–79 years died because of diabetes or related complications and the proportion of deaths related to diabetes in the same age group in South Africa, is between 5% and 8%.1
The prevention of T2DM-related complications, including retinopathy, nephropathy, neuropathy, cardiovascular disease, amputation and premature death, depends on early and efficient glycaemic control among patients.2,8,9 Maintaining optimal glycaemic control, as measured by haemoglobin A1c (HbA1c) levels below 7%, continues to be a significant challenge for many individuals living with T2DM. Despite advances in diabetes management strategies and treatments, a substantial number of patients struggle to consistently achieve these recommended glycaemic targets. Studies conducted in hospitals and primary care settings show that individuals with T2DM are not adequately managed; glycaemic target attainment rates or the proportion of T2DM patients whose glycated HbA1c is successfully lowered to less than or equal to 7%, range from 10% to 35%.10,11,12,13,14,15
Research indicates that patients with T2DM encounter numerous systemic barriers to effective glycaemic control, including poor adherence to medication and lifestyle regimens, socioeconomic constraints, irregular blood glucose monitoring, limited access to healthcare resources and education, staff shortages resulting in excessive workloads and clinicians’ hesitancy to escalate treatment when clinically indicated.16,17,18,19,20 These compounding challenges highlight the urgent need for comprehensive health system reforms to improve diabetes care delivery and outcomes. The recent enactment of South Africa’s National Health Insurance (NHI) Bill represents a pivotal step towards universal health coverage, building upon earlier initiatives including the 2011 NHI Green Paper, 2012 pilot projects and 2015 White Paper. However, full NHI implementation remains a gradual process requiring multisectoral collaboration.21
South Africa’s health system strengthening approach, aligned with World Health Organization (WHO) building blocks (human resources, financing, governance, information systems, medical products and service delivery), is being operationalised through NHI and primary healthcare re-engineering. The phased NHI implementation commenced with quality improvement initiatives (2012–2016), including facility audits and establishment of the Office of Health Standards Compliance. The subsequent phase (2017–2021) focused on legislative development and creating NHI fund structures, while the current phase (2022–2025) aims to achieve full NHI functionality.21,22 These reforms are particularly crucial for chronic disease management, where systemic weaknesses most acutely affect patient outcomes.
To inform targeted interventions that enhance both patient outcomes and healthcare worker support, this study aimed to examine the challenges and barriers faced by healthcare professionals in managing and monitoring patients living with T2DM within Tshwane District Municipality. By elucidating frontline barriers, from resource limitations to workflow inefficiencies, the research aims to provides evidence to strengthen diabetes care within the evolving NHI framework, ultimately contributing to more responsive chronic disease management systems under universal health coverage.
Research methods and design
Study design
This cross-sectional descriptive study was conducted among healthcare professionals employed in clinics and community health centres across the Tshwane Metropolitan Municipality, in the Gauteng province of South Africa. The study took place between May 2022 and July 2022.
Study setting
The Tshwane Metropolitan Municipality, which is one of the three metropolitan municipalities in the Gauteng province of South Africa, is the administrative capital of the country. This municipality is divided into 7 regions and encompasses a total of 103 clinics, 8 community health centres (CHCs), 1 regional hospital, 2 academic hospitals and 4 district hospitals. The study was conducted across 5 randomly selected regions and included a sample of 22 clinics and 6 CHCs.
Study population, inclusion and exclusion criteria
The study population comprised nurses and medical doctors working in the PHC clinics and CHCs. Participants were above 18 years of age, with at least 1 year of working experience in providing comprehensive treatment, care and management for patients diagnosed with T2DM. Healthcare professionals working in hospitals or private practice, those with limited experience in treating patients with T2DM, those unwilling or unable to provide informed consent or absent at the time of data collection were excluded from the study.
Sample size and sampling strategies
The actual numbers of HCP who treated patients with T2DM was unknown and differed per facility, ranging from 2 to 20. Therefore, an estimated 2084 HCPs in Tshwane was used to determine the required minimum sample size (personal communication). The Cochrane’s sample size calculation for proportions was used to calculate the minimum sample size using a distribution rate of 80%, 5% margin of error and 95% confidence interval. The minimum required sample size was 246, and this was increased to 250.
All available HCPs responsible for the care and treatment of patients with T2DM and had agreed to participate, where included in the study. Participants were recruited as a group in their respective facilities, mostly during their morning meetings. The purpose of the study and rights to voluntary participation were presented prior to obtaining verbal informed consent.
Data collection
A structured, standardised and self-administered questionnaire was used to collect data from the study participants. Literature was utilised to guide the development of the main tool.20,23 The original tool had 5 main sections, namely the sociodemographic information, management and monitoring of patients, barriers to effective management of patients and behavioural intention of healthcare providers to use real-time continuous glucose monitoring among patients with T2DM. The tool had closed and a few open-ended questions. The tool had 20 questions that examined barriers to effective management of patients with T2DM. Of those, 12 focused on individual-level barriers, while 6 addressed system-level barriers and the rest focused on sociodemographic characteristics. The individual-level barrier questions explored issues such as healthcare providers’ knowledge, skills, workload, time constraints, language barriers and perceived roles in the treatment and care of patients. The system-level barrier questions investigated resource and practice-related challenges.
Participants were required to indicate whether they agreed or disagreed with the statements. An interview lasted for about 10 min to 20 min. Data collection lasted for about 10 weeks, from May 2022 to July 2022. Google Forms (Google, LLC) was used to capture data to minimise data entry errors. After the collection period, data were exported into Microsoft Excel (Microsoft Corp) prior to importation into STATA for cleaning, coding and analysis.
Data analysis
Data analyses were conducted using STATA 17 SE (College Station, Texas: StataCorp, LLC, United States). Descriptive statistics were presented as mean and standard deviation for continuous variables and as count and proportion for categorical variables. The researchers employed Fisher’s exact test to compare the perceptions of nurses and doctors regarding the barriers encountered in providing care for patients with T2DM. A p-value of less than or equal to 0.05 was considered to be statistically significant for the purposes of this analysis.
Ethical considerations
Ethical clearance was obtained from Sefako Makgatho Health Sciences University Research Ethics Committee (No. SMUREC/H/318/2021:PG).
Permission to conduct the study was obtained from the Gauteng Provincial Department of Health and the Tshwane District Research Committee. Further permission was obtained from the facility operations managers of the primary healthcare facilities that participated in the study. This study was conducted in line with the Declaration of Helsinki. Participants were informed about the purpose of the study, their rights to voluntary participation and withdrawal from the study at any point, without any consequences. Participants preferred to consent verbally and this was obtained prior to completing the questionnaires. The study was anonymised to ensure confidentially and privacy of the participants. All identifiable information of the facilities were de-linked.
Results
Demographic characteristics
A total of 250 questionnaires were distributed, and of those, 205 were completed, which resulted in a response rate of 82%. The mean age of the participants was 44 ± 11.1 years (ranged from 24 years to 67 years). Most participants were over 40 years old (62%, n = 128), female (87%, n = 179) and of black African descent (86%, n = 177). The majority were nurses (84%, n = 173), in contrast with medical doctors (16%, n = 32) (Table 1). Although not included in the table, of the nurses and doctors in the study, 91% (n = 157) were professional nurses while 47% (n = 15) were medical officers and registrars, respectively. Most of the participants were employed in the primary healthcare clinics (81%, n = 165) and 65% (n = 132) had more than 10 years of working experience in the setting. In terms of clinical experience of managing patients with T2DM, 35% (n = 72) had more than 10 years of experience. About 39% (n = 79) reported to have received training on T2DM while pursuing their degrees and during in-house training workshops.
| TABLE 1: Demographic information of the participants, (N = 205). |
Barriers to effective management of patients with type 2 diabetes mellitus
Table 2 details the healthcare professionals’ perspectives on the key obstacles and challenges they face in the effective management of patients with T2DM.
| TABLE 2: Barriers to effective management of patients with type 2 diabetes mellitus. |
Workload
Overall, more than half of the participants indicated that heavy workloads imposed a challenge in their ability to effectively manage and monitor patients with diabetes mellitus (53%, n = 108), and adequately screen those with complications related to the disease (57%, n = 117). Compared to nurses, doctors, significantly reported to have heavy workload and demanding schedules making it extremely challenging for them to effectively monitor patients (75% vs. 49%, p = 0.007) and thoroughly screen patients with T2DM for any related complications (78% vs. 53%, p = 0.011).
Time pressure
Many of the participants (59%, n = 120) reported that the time pressure they face in their clinical practice makes it challenging for them to consistently deliver high-quality care to patients with diabetes. A significant difference was observed between nurses and doctors and this issue was notably more prevalent among doctors than nurses (81% vs. 54%, p = 0.006). Because of the time constraint, 69% (n = 141) of the participants lacked the time to sit with patients and comprehensively educate them about the disease and lifestyle modification. Although most doctors reported not having adequate time than nurses (81% vs. 64%, p = 0.145), the results were, however, not statistically significant.
Language barriers
Several participants (32%, n = 65) reported that language barrier presents a challenge in providing appropriate care for patients with T2DM. Doctors were more likely to experience language barriers compared to nurses (44% vs. 29%, p = 0.147), although the results were not statistically significant.
Perceived role
Most participants (88%, n = 181) acknowledged that it is their responsibility to screen patients for complications related to diabetes. A statistically significant difference was observed between doctors and nurses (100% vs. 86%, p = 0.017).
Knowledge and skills
Most (81%, n = 166) of the participants indicate that they possessed the necessary knowledge and skills to intensify diabetes treatment, and this was significantly reported by doctors compared with nurses (97% vs. 78%, p = 0.012). The results further indicate that most participants (81%, n = 167) were adequately trained to provide patients with health-related lifestyle modification guidance, with doctors more often making this claim than nurses, even though the difference was not statistically significant (91% vs. 80%, p = 0.215). A small proportion (16%, n = 33) of participants indicated that they lacked the necessary knowledge and skills to determine whether patients were properly managed, and this was more frequently reported by nurses than doctors; however, this difference was also not statistically significant (17% vs. 13%, p = 0.793).
Most participants (84%, n = 177) disagreed with the idea that they might occasionally delay treatment for patients because of concerns about potential medication side effects. There was no significant difference observed between nurses and doctors (88% vs. 78%, p = 0.161). Several participants (32%, n = 65) reported having adequate knowledge and skills to commence insulin treatment for patients who require it, with a notably larger proportion of doctors possessing this knowledge compared to nurses (84% vs. 22%, p = 0.001). About 73% (n = 149) also reported that they have sufficient knowledge and skills to recommend treatment intensification or adjustment, with no significant disparity observed between doctors and nurses (69% vs. 72%, p > 0.05)
Resources and monitoring of glycaemic control
The majority of the participants reported that the facility has appropriate equipment to effectively manage and monitor patients with diabetes (72%, n = 147), has some protocols in place to structured care related to diabetes (77%, n = 157), has access to HbA1c testing, which is not a significant issue (88%, n = 181), has a system that allows clinicians to be aware of the patient’s previous visit details (89%, n = 182) and relies on the patient’s file to track their history (71%, n = 146). In addition, there was no notable difference between doctors and nurses in these aspects (p > 0.05).
Practices related to diabetes care
A small number of participants (25%, n = 52) reported that coordinating diabetes care is a challenge in their practice setting, with no difference observed between doctors and nurses (31% vs. 24%, p = 0.387). However, many (62%, n = 128) stated that the lack of continuity of care for patients makes it hard for them to effectively monitor and manage patients with T2DM, and again no significant difference between doctors and nurses was observed (75% vs. 60%, p = 0.118).
Discussion
The study aimed to investigate the key barriers hindering effective management of patients with T2DM. Our findings revealed that excessive workloads posed significant challenges for healthcare professionals, particularly in monitoring patients and screening for diabetes-related complications. Notably, this issue was more frequently reported by doctors compared to nurses. Research has consistently shown that inadequate staffing results in elevated workloads, creating a high patient-to-clinician ratio.19,20 Such conditions often lead to diminished quality of care, increased medical errors, lower patient satisfaction and burnout among healthcare providers.24,25,26 Addressing this issue requires strategic interventions, such as reassessing staffing levels, enhancing workflow efficiency and leveraging technological solutions. Implementing these changes could help alleviate the strain on healthcare teams and foster more effective and holistic diabetes management.
Another challenge faced by healthcare professionals in the management of T2DM is the significant work-related pressure affecting the quality of care and time to educate patients about the disease and lifestyle modification. Several studies have reported similar constraints faced by healthcare professionals,19,20 which may contribute to difficulty in providing comprehensive and personalised care for patients with diabetes.20,27,28 These pressures can potentially limit the time and attention healthcare professionals dedicate to educating patients, monitoring their condition and implementing effective treatment plans.18,29 Investing in health technology, such as conversational agents (tailored to patients’ literacy, age, culture and socioeconomic status), continuous glucose monitoring and electronic health records can help address barriers in patient education, monitoring and management. These tools have the potential to empower patients to manage their conditions while reducing the strain on healthcare professionals.30,31,32
In this study, few of the participants had enough knowledge and skills to initiate insulin therapy for patients who required it, and doctors were more likely to be knowledgeable than nurses in this regard. This is consistent with another study where most healthcare professionals reported lacking confidence in their ability to initiate insulin therapy citing insufficient information or resources.33 Developing and maintaining up-to-date knowledge and skills in the comprehensive management of patients, including the initiation and titration of insulin therapy, is critical for providing high-quality, evidence-based care.27 Therefore, nurses need to be continuously educated about the proper protocols and best practices for managing insulin therapy for the patients in order to deliver the most effective care and improved outcomes.34
A few participants also indicated that the persistent unavailability of essential resources remained a significant challenge for the effective management of patients with T2DM. Interestingly, this issue was more frequently reported by doctors than nurses, although the difference in their responses was not statistically significant. The unavailability of essential resources, such as equipment and supplies, needs to be addressed urgently in order to ensure the provision of high-quality diabetes care. A multicentric cross-sectional study conducted in the Democratic Republic of the Congo health facilities found that most of the facilities lack of equipment for management of patients living with diabetes.35 Studies conducted in the Tshwane reported that some of the critical equipment required to provide high-quality diabetes-related care were unavailable to the healthcare professionals.23,36
The findings of this study suggest that the majority of participants reported difficulties in effectively monitoring patients with T2DM because of a lack of continuity of care. This concern was more prevalent among physicians compared to nurses although the differences were not statistically significant. Continuing medical care, patient self-management education and support can help prevent acute complications and reduce the risk of long-term T2DM complications.37 Bosire and colleagues describe continuity of care as collaborative care, which they often find lacking in primary healthcare facilities because of insufficient staffing.28 The authors suggest that collaborative care can facilitate patient-centred care, particularly when provided by a team. Similarly, Haque and colleagues found that inadequate staffing contributes to a lack of continuity of care, which represents a significant barrier.38 Therefore, it is crucial to implement strategies that ensure ongoing and coordinated care for patients, which would ultimately enhance disease management and patient outcomes.
Limitations
There are several limitations to be noticed in this study. Because of the small number of healthcare professionals dedicated to the treatment and care of patients with T2DM, this study used consecutive sampling technique and recruited eligible participants who were available at the facility on the day of data collection, thus potentially introducing self-selection bias. Although the study took place in 22 clinics and 6 CHCs, the small sample size may result in some potential external generalisability of the findings. Furthermore, the study relied on self-reported data from the healthcare professionals, which may have aspects of social desirability bias, leading to favourable responses in other aspects. A review of clinical records and audits could provide more accurate insights into diabetes care practices because these may vary across clinics and CHCs. The availability of resources, clinic size, patient load and infrastructure were not accounted for in this study, and this could have had an influence on the overall responses related to care provision. Despite these limitations, this study has shed some light on the management and care of patients with T2DM and highlighted key barriers that are also supported by the literature and further warrants attention.
Conclusion
This study identifies several key barriers to effective T2DM management, including excessive workloads among healthcare professionals, inadequate staffing leading to high patient-clinician ratios and time constraints that compromise personalised care and patient education. Knowledge gaps in insulin therapy initiation (especially among nurses) and persistent shortages of essential medical resources further hinder optimal care delivery. The lack of continuity of care, exacerbated by insufficient staffing, emerges as a critical concern, aligning with the existing literature on collaborative care models. These findings underscore the need for comprehensive interventions including workforce optimisation, targeted training programmes, improved resource allocation and enhanced care coordination and use of health technology to address both healthcare professionals’ challenges and patient outcomes in T2DM management.
Acknowledgements
Mr Nobhozoyi Makhi for capturing the data. The Tshwane District Research Committee and Gauteng Department Health Research Committee for providing permission to conduct the study in Tshwane primary healthcare (PHC). All PHCs facility managers for the warm welcome in their facilities and lastly all HCPs who took time off their busy scheduled and participated in the study. This article is partially based on the authors PhD thesis titled ‘Behavioural intention of Health Care workers to use real-time continuous glucose monitoring among patients with Type 2 diabetes mellitus in Tshwane’ towards the degree of PhD in Public Health in the Department of Public Health, Sefako Makgatho Health Sciences University, South Africa, with supervisors Prof. Paul Chelule and Dr Sam Ntuli, received Jan 2024, available at www.smu.ac.za.
Competing interests
The author reported that they received funding from University Capacity Development Grant (UCDG), number D435, which was provided by Sefako Makgatho Health Sciences University through the South African National Department of Higher Education and Training, which may be affected by the research reported in the enclosed publication. The author has disclosed those interests fully and has implemented an approved plan for managing any potential conflicts arising from their involvement. The terms of these funding arrangements have been reviewed and approved by the affiliated university in accordance with its policy on objectivity in research.
Authors’ contributions
N.M.M. is responsible for the conceptualisation, drafting the original article, methodology, data analysis, data curation, review, editing and submission. T.S.N. is responsible for data analysis, data curation, methodology, drafting the original article, review and supervision. P.K.C. is responsible for resources, methodology, review and supervision. T.S.N. is responsible for review, editing, validation and administration. All authors provided critical feedback, read and agreed to publish the article.
Funding information
This research and publication was made possible with support from the University Capacity Development Grant (UCDG), number D435, which was provided by Sefako Makgatho Health Sciences University through the South African National Department of Higher Education and Training.
Data availability
The data that support the findings of this study are available from the corresponding author, N.M.M., upon reasonable request.
Disclaimer
The views and opinions expressed in this article are those of the authors and are the product of professional research. It does not necessarily reflect the official policy or position of any affiliated institution, funder, agency or that of the publisher. The authors are responsible for this article’s results, findings and content.
References
- International Diabetes Federation. Diabetes Atlas [homepage on the Internet]. 2025 [cited 2025 June 29]. Available form: https://diabetesatlas.org/media/uploads/sites/3/2025/04/IDF_Atlas_11th_Edition_2025.pdf
- SEMDSA. SEMDSA 2017 Guidelines for the management of Type 2 diabetes mellitus. J Endocrinol Metabol Diabetes S Afr. 2017;22(1):S30–S33.
- Assah F, Mbanya JC. Diabetes in sub-Saharan Africa. In: Dagogo-Jack S, editor. Diabetes mellitus in developing countries and underserved communities. Cham: Springer International Publishing; 2017. p. 33–48.
- Bailey CJ. Under-treatment of type 2 diabetes: Causes and outcomes of clinical inertia. Int J Clin Pract. 2016;70(12):988–995. https://doi.org/10.1111/ijcp.12906
- Mutyambizi C, Chola L, Groot W, Pavlova M, Labadarios D, Hongoro C. The extent and determinants of diabetes and cardiovascular disease comorbidity in South Africa – Results from the South African National Health and Nutrition Examination Survey (SANHANES-1). BMC Public Health. 2017;17(1):1–11. https://doi.org/10.1186/s12889-017-4792-8
- Shisana O, Labadarios D, Rehle T, et al. South African National Health and Nutrition Examination Survey (SANHANES-1) [homepage on the Internet]. HSRC Press; 2013. Available from: http://www.hsrc.ac.za/uploads/pageNews/72/SANHANES-launchedition(onlineversion).pdf
- Pheiffer C, Wyk VP Van, Turawa E, Levitt N, Kengne AP, Bradshaw D. Prevalence of type 2 diabetes in South Africa: A systematic review and meta-analysis. Int J Environ Res Public Health. 2021;18(11):5868. https://doi.org/10.3390/ijerph18115868
- Danese E, Montagnana M, Nouvenne A, Lippi G. Advantages and pitfalls of fructosamine and glycated albumin in the diagnosis and treatment of diabetes. J Diabetes Sci Technol. 2015;9(2):169–176. https://doi.org/10.1177/1932296814567227
- Strain WD, Blüher M, Paldánius P. Clinical inertia in individualising care for diabetes: Is there time to do more in Type 2 Diabetes?. Diabetes Ther. 2014;5(2):347–354. https://doi.org/10.1007/s13300-014-0077-8
- Pinchevsky Y, Butkow N, Chirwa T, Raal F. Treatment gaps found in the management of type 2 diabetes at a community health centre in Johannesburg, South Africa. J Diabetes Res. 2017;2017:9536025. https://doi.org/10.1155/2017/9536025
- Kibirige D, Akabwai GP, Kampiire L, Kiggundu DS, Lumu W. Frequency and predictors of suboptimal glycemic control in an African diabetic population. Int J Gen Med. 2017;10:33–38. https://doi.org/10.2147/IJGM.S124548
- Khattab M, Khader YS, Al-Khawaldeh A, Ajlouni K. Factors associated with poor glycemic control among patients with Type 2 diabetes. J Diabetes Complicat. 2010;24(2):84–89. https://doi.org/10.1016/j.jdiacomp.2008.12.008
- Kalain A, Omole OB. Lifestyle advice, processes of care and glycaemic control amongst patients with type 2 diabetes in a South African primary care facility. Afr J Prim Health Care Fam Med. 2020;12(1):a2163. https://doi.org/10.4102/phcfm.v12i1.2163
- Govender RD, Gathiram P, Panajatovic M. Poor control and management of type 2 diabetes mellitus at an under-resourced south african hospital: Is it a case of clinical inertia?. S Afr Fam Pract. 2017;59(5):154–159. https://doi.org/10.1080/20786190.2017.1307909
- Bulbulia S, Variava F, Bayat Z. Are type 2 diabetic patients meeting targets? A Helen Joseph Hospital Diabetic Clinic Audit. J Endocrinol Metabol Diabetes S Afr. 2020;25(1):12–17. https://doi.org/10.1080/16089677.2019.1692471
- Park PH, Pastakia SD. Access to Hemoglobin A1c in rural Africa: A difficult reality with severe consequences. J Diabetes Res. 2018;2018:6093595. https://doi.org/10.1155/2018/6093595
- Polonsky WH, Henry RR. Poor medication adherence in type 2 diabetes: Recognizing the scope of the problem and its key contributors. Patient Prefer Adherence. 2016;10:1299–1307. https://doi.org/10.2147/PPA.S106821
- Mancini N, Campbell R, Yaphe H, et al. Identifying challenges and solutions to providing diabetes care for those experiencing homelessness. Int J Homeless. 2021;2(1):48–67. https://doi.org/10.5206/ijoh.2022.1.13643
- Maimela E, Van Geertruyden JP, Alberts M, et al. The perceptions and perspectives of patients and health care providers on chronic diseases management in rural South Africa: A qualitative study. BMC Health Serv Res. 2015;15(1):143. https://doi.org/10.1186/s12913-015-0812-5
- Rushforth B, McCrorie C, Glidewell L, Midgley E, Foy R. Barriers to effective management of type 2 diabetes in primary care: Qualitative systematic review. Br J Gen Pract. 2016;66(643):e114–e127. https://doi.org/10.3399/bjgp16X683509
- Michel J, Obrist B, Bärnighausen T, et al. What we need is health system transformation and not health system strengthening for universal health coverage to work: Perspectives from a National Health Insurance pilot site in South Africa. S Afr Fam Pract. 2020;62(1):5079. https://doi.org/10.4102/safp.v62i1.5079
- Pauw TL. Catching up with the constitution: An analysis of National Health Insurance in South Africa post-apartheid. Dev South Afr. 2022;39(6):921–934. https://doi.org/10.1080/0376835X.2021.1945911
- Webb EM, Rheeder P, Wolvaardt JE. The ability of primary healthcare clinics to provide quality diabetes care: An audit. Afr J Prim Health Care Fam Med. 2019;11(1):2094. https://doi.org/10.4102/phcfm.v11i1.2094
- Abraham CM, Zheng K, Norful AA, Ghaffari A, Liu J, Poghosyan L. Primary care nurse practitioner burnout and perceptions of quality of care. Nurs Forum (Auckl). 2021;56(3):12579. https://doi.org/10.1111/nuf.12579
- Menon NK, Shanafelt TD, Sinsky CA, et al. Association of physician burnout with suicidal ideation and medical errors. JAMA Netw Open. 2020;3(12):28780. https://doi.org/10.1001/jamanetworkopen.2020.28780
- Li CJ, Shah YB, Harness ED, Goldberg ZN, Nash DB. Physician burnout and medical errors: Exploring the relationship, cost, and solutions. Am J Med Qual. 2023;38(4):196–202. https://doi.org/10.1097/JMQ.0000000000000131
- Almossawi HJ, Matji R, Pillay Y, Singh S, Mvusi L, Mbambo B. Primary health care system readiness for diabetes mellitus and tuberculosis service integration in South Africa. J Trop Dis. 2019;7:329.
- Bosire EN, Norris SA, Goudge J, Mendenhall E. Pathways to care for patients with type 2 diabetes and HIV/ AIDS comorbidities in Soweto, South Africa: An ethnographic study. Glob Health Sci Pract. 2021;9(1):15–30. https://doi.org/10.9745/GHSP-D-20-00104
- Barnes CS, Ziemer DC, Miller CD, et al. Little time for diabetes management in the primary care setting. Diabetes Educ. 2004;30(1):126–135. https://doi.org/10.1177/014572170403000120
- Griffin AC, Xing Z, Khairat S, et al. Conversational agents for chronic disease self-management: A systematic review. AMIA Annu Symp Proc [serial online]. 2021 [cited 2025 June 29];2020:504–513. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC8075433/
- Vigersky R, Shrivastav M. Role of continuous glucose monitoring for type 2 in diabetes management and research. J Diabetes Complicat. 2017;31(1):280–287. https://doi.org/10.1016/j.jdiacomp.2016.10.007
- Sands DZ. Beyond the EHR: How digital health tools foster participatory health and self-care for patients with diabetes. Am J Med Open. 2023;10:100043. https://doi.org/10.1016/j.ajmo.2023.100043
- McDermott JM, Levine B, Lackner J, Shoger E, Close KL. 56-LB: HCP information: Drowning in resources, lacking confidence?. Diabetes. 2019;68(suppl_1):56-LB. https://doi.org/10.2337/db19-56-LB
- Levine BJ, Close KL, Dalton D, et al. Enhancing resources for healthcare professionals caring for people on intensive insulin therapy: Summary from a national workshop. Diabetes Res Clin Pract. 2020;164:108169. https://doi.org/10.1016/j.diabres.2020.108169
- Kapongo RY, Lulebo AM, Mafuta EM, Mutombo PB, Dimbelolo JCM, Bieleli IE. Assessment of health service delivery capacities, health providers’ knowledge and practices related to type 2 diabetes care in Kinshasa primary healthcare network facilities, Democratic Republic of the Congo. BMC Health Serv Res. 2015;15(1):1–6. https://doi.org/10.1186/s12913-015-0679-5
- Mogale NM, Ntuli TS, Dhlamini TS, Chelule PK. Quality of care provided to patients with type 2 diabetes mellitus in Tshwane, South Africa. Afr J Prim Health Care Fam Med. 2024;16(1):8. https://doi.org/10.4102/phcfm.v16i1.4576
- American Diabetes Association. Standards of medical care in diabetes – 2012. Diabetes Care. 2012;35(suppl. 1):S11–S63. https://doi.org/10.2337/dc12-s011
- Haque M, Navsa M, Emerson SH, Dennison CR, Levitt NS. Barriers to initiating insulin therapy in patients with type 2 diabetes mellitus in public-sector primary health care centres in Cape Town. J Endocrinol Metabol Diabetes S Afr. 2005;10(3):94–99. https://doi.org/10.1080/22201009.2005.10872127
|